chr22-50064221-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015166.4(MLC1):c.895-23C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.146 in 1,574,750 control chromosomes in the GnomAD database, including 17,706 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.12 ( 1260 hom., cov: 34)
Exomes 𝑓: 0.15 ( 16446 hom. )
Consequence
MLC1
NM_015166.4 intron
NM_015166.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.733
Publications
5 publications found
Genes affected
MLC1 (HGNC:17082): (modulator of VRAC current 1) The function of this gene product is unknown; however, homology to other proteins suggests that it may be an integral membrane transporter. Mutations in this gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts, an autosomal recessive neurological disorder. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
MLC1 Gene-Disease associations (from GenCC):
- megalencephalic leukoencephalopathy with subcortical cysts 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Myriad Women’s Health
- megalencephalic leukoencephalopathy with subcortical cystsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 22-50064221-G-A is Benign according to our data. Variant chr22-50064221-G-A is described in ClinVar as Benign. ClinVar VariationId is 262461.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.218 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MLC1 | NM_015166.4 | c.895-23C>T | intron_variant | Intron 10 of 11 | ENST00000311597.10 | NP_055981.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MLC1 | ENST00000311597.10 | c.895-23C>T | intron_variant | Intron 10 of 11 | 1 | NM_015166.4 | ENSP00000310375.6 | |||
| MLC1 | ENST00000395876.6 | c.895-23C>T | intron_variant | Intron 10 of 11 | 1 | ENSP00000379216.2 | ||||
| MLC1 | ENST00000483836.1 | n.252-23C>T | intron_variant | Intron 3 of 4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.122 AC: 18565AN: 152094Hom.: 1259 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
18565
AN:
152094
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.126 AC: 24253AN: 192352 AF XY: 0.132 show subpopulations
GnomAD2 exomes
AF:
AC:
24253
AN:
192352
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.149 AC: 211760AN: 1422536Hom.: 16446 Cov.: 38 AF XY: 0.151 AC XY: 106589AN XY: 706068 show subpopulations
GnomAD4 exome
AF:
AC:
211760
AN:
1422536
Hom.:
Cov.:
38
AF XY:
AC XY:
106589
AN XY:
706068
show subpopulations
African (AFR)
AF:
AC:
2399
AN:
33170
American (AMR)
AF:
AC:
5437
AN:
40970
Ashkenazi Jewish (ASJ)
AF:
AC:
2135
AN:
25542
East Asian (EAS)
AF:
AC:
3893
AN:
38830
South Asian (SAS)
AF:
AC:
18143
AN:
83210
European-Finnish (FIN)
AF:
AC:
3555
AN:
37182
Middle Eastern (MID)
AF:
AC:
788
AN:
5474
European-Non Finnish (NFE)
AF:
AC:
166964
AN:
1098836
Other (OTH)
AF:
AC:
8446
AN:
59322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.418
Heterozygous variant carriers
0
9849
19697
29546
39394
49243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6094
12188
18282
24376
30470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.122 AC: 18572AN: 152214Hom.: 1260 Cov.: 34 AF XY: 0.123 AC XY: 9117AN XY: 74418 show subpopulations
GnomAD4 genome
AF:
AC:
18572
AN:
152214
Hom.:
Cov.:
34
AF XY:
AC XY:
9117
AN XY:
74418
show subpopulations
African (AFR)
AF:
AC:
3112
AN:
41554
American (AMR)
AF:
AC:
2658
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
269
AN:
3470
East Asian (EAS)
AF:
AC:
506
AN:
5168
South Asian (SAS)
AF:
AC:
1104
AN:
4824
European-Finnish (FIN)
AF:
AC:
910
AN:
10616
Middle Eastern (MID)
AF:
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9563
AN:
67964
Other (OTH)
AF:
AC:
309
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
835
1671
2506
3342
4177
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
538
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Megalencephalic leukoencephalopathy with subcortical cysts 1 Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.